• Alburex 20

  Form: solution for infusion

  Active substance	Dosage
  total protein less or equal to 96% human albumin	200 g

  ATC: B05AA01

• Alburex 5

  Form: solution for infusion

  Active substance	Dosage
  total protein	50 g

  ATC: B05AA01

• Beriate 2000

  Form: solution for injection / infusion, powder and solvent for preparation of

  ATC: B02BD02

• Berinert 1500

  Form: solution for injection, powder and solvent for preparation of

  Active substance	Dosage
  Human C1 esterase inhibitor	450-625 IU/ml

  ATC: B02AB03

• Berinert 2000

  Form: solution for injection, powder and solvent for preparation of

  Active substance	Dosage
  Human C1 esterase inhibitor	2000 j.m.

  ATC: B06AC01

• Berinert 3000

  Form: solution for injection, powder and solvent for preparation of

  Active substance	Dosage
  Human C1 esterase inhibitor	3000 j.m.

  ATC: B06AC01

• Berinert 500

  Form: solution for injection or infusion, powder and solvent for preparation of

  Active substance	Dosage
  Human C1 esterase inhibitor	40.0 - 62.5 J/ml

  ATC: B06AC01

• Beriplex p/n 1000

  Form: solution for injection, powder and solvent for preparation of

  Active substance	Dosage
  Human prothrombin complex	1000 j.m.

  ATC: B02BD01

• Beriplex p/n 250

  Form: solution for injection, powder and solvent for preparation of

  Active substance	Dosage
  human coagulation factor II	200-480 j.m.
  human coagulation factor VII	100-250 j.m.
  human coagulation factor IX	200-310 IU
  human coagulation factor X	220-600 j.m.
  C protein	150-450 j.m.
  S protein	130-260 j.m.

  ATC: B02BD01

• Beriplex p/n 500

  Form: solution for injection, powder and solvent for preparation of

  Active substance	Dosage
  human coagulation factor X	440-1200 j.m.
  human coagulation factor VII	200-500 j.m.
  C protein	300-900 j.m.
  human coagulation factor IX	400-620 j.m.
  S protein	260-520 j.m.
  human coagulation factor II	400-960 j.m.

  ATC: B02BD01

• Cluvot 1250 j.m.

  Form: powder and solvent for solution for injection and infusion

  Active substance	Dosage
  Factor XIII	1250 j.m. (1000 - 1600 j.m.)

  ATC: B02BD07

• Cluvot 250 j.m.

  Form: powder and solvent for solution for injection and infusion

  Active substance	Dosage
  Factor XIII	250 IU (200 - 320 IU)

  ATC: B02BD07

• Haemate p 1000 units fviii/2400 units vwf

  Form: solution for injection or infusion, powder and solvent for preparation of

  Active substance	Dosage
  human coagulation factor VIII	1000 j.m.
  von Willebrand factor human	2400 j.m.

  ATC: B02BD06

• Haemate p 250 j.m. fviii/600 j.m. vwf

  Form: solution for injection or infusion, powder and solvent for preparation of

  Active substance	Dosage
  human coagulation factor VIII	250 j.m.
  von Willebrand factor human	600 j.m.

  ATC: B02BD06

• Haemate p 500 u. fviii/1200 u. vwf

  Form: solution for injection or infusion, powder and solvent for preparation of

  Active substance	Dosage
  human coagulation factor VIII	500 j.m.
  von Willebrand factor human	1200 j.m.

  ATC: B02BD06

• Human albumin csl behring 200 g/l

  Form: solution for infusion

  Active substance	Dosage
  total protein	200 g/l

  ATC: B05AA01

• Kybernin p

  Form: powder and solvent for preparation of infusion solution

  Active substance	Dosage
  Antithrombin III	up to 1 ml

  ATC: B01AB02

• Rhophylac 300

  Form: solution for injection

  Active substance	Dosage
  Human anti-D immunoglobulin	300 mcg (1500IU)/2 ml

  ATC: J06BB01

• Riastap

  Form: powder for preparation of solution for injection or infusion

  Active substance	Dosage
  Human fibrinogen	1 g

  ATC: B02BB01

• Water for injections csl behring

  Form: solution for preparation of parenteral drugs

  Active substance	Dosage
  Water for injection	No input provided

  ATC: V07AB